Investigation of the effect of licophar tablet on sore throat of patients undergoing cataract surgery after insertion of laryngeal mask airway

Investigation of the effect of licophar tablet on reduction of the sore throat of patients undergoing cataract surgery after insertion of laryngeal mask airway

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170415033428N4

Enrollment

160

Registered

2020-03-15

Start date

2020-02-17

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract. Disorders of the eye following cataract surgery

Interventions

Intervention 1: Intervention group: Licophar Lozenge (produced by Goldaru company) will be given to patients half an hour before surgery. Intervention 2: Control group: No drug will be used.

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: patients undergoing cataract surgery with operating time of less than 60 minutes

Exclusion criteria

Exclusion criteria: use of NSAIDS in the past 2 days use of drugs and cigarettes upper airway problem (obesity, patients with ASA above 2, swollen tonsils) asthma pharyngitis neuromuscular problems (such as Myasthenia gravis – ALS) mental health problems in a way that the intended outcome cannot be evaluated in the patient excessive obesity (BMI > 35) diabetes, hypertension, being in pregnancy or lactation

Design outcomes

Primary

Measure	Time frame
Rate of sore throat. Timepoint: at 3,6,12 and 24 hours after operation. Method of measurement: based on visual analog scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Alipour

Mashhad University of Medical Sciences

alipourm@mums.ac.ir+98 51 3852 5209

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026